title: How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.
authors.affiliation: Department of Internal Medicine, University of Münster, Federal Republic of Germany.
authors.forename: T
authors.initials: T
authors.lastname: Büchner
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: G
authors.initials: G
authors.lastname: Maschmeyer
authors.forename: W
authors.initials: W
authors.lastname: Ludwig
authors.forename: H
authors.initials: H
authors.lastname: Löffler
authors.forename: M
authors.initials: M
authors.lastname: Nowrousian
authors.forename: C
authors.initials: C
authors.lastname: Aul
authors.forename: A
authors.initials: A
authors.lastname: Heinecke
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D015996:Survival Rate; D013866:Thioguanine / Q000627:therapeutic use
chemical_list: D003115:Colony-Stimulating Factors; D006133:Growth Substances; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D013866:Thioguanine; D003630:Daunorubicin